122 related articles for article (PubMed ID: 32520662)
1. Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.
Rocchi C; Pulcini A; Vesprini C; Totaro V; Viticchi G; Falsetti L; Danni MC; Bartolini M; Silvestrini M; Buratti L
Neurol Res; 2020 Sep; 42(9):744-748. PubMed ID: 32520662
[TBL] [Abstract][Full Text] [Related]
2. Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study.
Rocchi C; Lombardi L; Broggi S; Danni MC; Lattanzi S; Viticchi G; Falsetti L; Bartolini M; Silvestrini M; Buratti L
CNS Neurol Disord Drug Targets; 2023; 22(7):1102-1108. PubMed ID: 35570517
[TBL] [Abstract][Full Text] [Related]
3. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
Mendozzi L; Tronci F; Garegnani M; Pugnetti L
Mult Scler; 2010 Feb; 16(2):238-47. PubMed ID: 20028705
[TBL] [Abstract][Full Text] [Related]
4. Sleep actigraphic patterns and cognitive status.
Buratti L; Camilletti R; Pulcini A; Rocchi C; Viticchi G; Falsetti L; Baldinelli S; Fiori C; Silvestrini M
J Integr Neurosci; 2021 Jun; 20(2):385-392. PubMed ID: 34258937
[TBL] [Abstract][Full Text] [Related]
5. The difference between in bed and out of bed activity as a behavioral marker of cancer patients: A comparative actigraphic study.
Natale V; Innominato PF; Boreggiani M; Tonetti L; Filardi M; Parganiha A; Fabbri M; Martoni M; Lévi F
Chronobiol Int; 2015; 32(7):925-33. PubMed ID: 26158757
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
Nikfar S; Rahimi R; Abdollahi M
Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.
Giménez S; Videla L; Romero S; Benejam B; Clos S; Fernández S; Martínez M; Carmona-Iragui M; Antonijoan RM; Mayos M; Fortuna A; Peñacoba P; Plaza V; Osorio RS; Sharma RA; Bardés I; Rebillat AS; Lleó A; Blesa R; Videla S; Fortea J
J Clin Sleep Med; 2018 Oct; 14(10):1725-1733. PubMed ID: 30353801
[TBL] [Abstract][Full Text] [Related]
8. The impact of drugs for multiple sclerosis on sleep.
Lanza G; Ferri R; Bella R; Ferini-Strambi L
Mult Scler; 2017 Jan; 23(1):5-13. PubMed ID: 27503906
[TBL] [Abstract][Full Text] [Related]
9. Sleep profile in a population of community-dwelling nonagenarians: data from the Mugello study.
Binazzi B; Provini F; Pancani S; Grippo A; Vannetti F; Pasquini G; Frandi R; Turcan N; Razzolini L; Cecchi F; Lova RM; Macchi C
Psychogeriatrics; 2023 May; 23(3):487-493. PubMed ID: 36967638
[TBL] [Abstract][Full Text] [Related]
10. Associations of self-report and actigraphy sleep measures with experimental pain outcomes in patients with temporomandibular disorder and healthy controls.
Boggero IA; Schneider VJ; Thomas PL; Nahman-Averbuch H; King CD
J Psychosom Res; 2019 Aug; 123():109730. PubMed ID: 31376882
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons.
van den Berg JF; Miedema HM; Tulen JH; Hofman A; Neven AK; Tiemeier H
Sleep; 2009 Oct; 32(10):1367-75. PubMed ID: 19848365
[TBL] [Abstract][Full Text] [Related]
12. Rest-activity circadian rhythm and sleep quality in patients with binge eating disorder.
Roveda E; Montaruli A; Galasso L; Pesenti C; Bruno E; Pasanisi P; Cortellini M; Rampichini S; Erzegovesi S; Caumo A; Esposito F
Chronobiol Int; 2018 Feb; 35(2):198-207. PubMed ID: 29144185
[TBL] [Abstract][Full Text] [Related]
13. Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence.
Filardi M; Pizza F; Martoni M; Vandi S; Plazzi G; Natale V
Sleep Med; 2015 Jan; 16(1):126-30. PubMed ID: 25547035
[TBL] [Abstract][Full Text] [Related]
14. Actigraphy assessment of sleep quality among patients with acute myeloid leukaemia during induction chemotherapy.
Yang CJ; Aibel K; Meyerhoff R; Wang F; Harpole D; Abernethy AP; LeBlanc TW
BMJ Support Palliat Care; 2018 Sep; 8(3):274-277. PubMed ID: 29643104
[TBL] [Abstract][Full Text] [Related]
15. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
Melamud L; Golan D; Luboshitzky R; Lavi I; Miller A
J Neurol Sci; 2012 Mar; 314(1-2):37-40. PubMed ID: 22137446
[TBL] [Abstract][Full Text] [Related]
16. Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis.
Munschauer FE; Kinkel RP
Clin Ther; 1997; 19(5):883-93. PubMed ID: 9385477
[TBL] [Abstract][Full Text] [Related]
17. 24-h activity rhythm and sleep in depressed outpatients.
Hori H; Koga N; Hidese S; Nagashima A; Kim Y; Higuchi T; Kunugi H
J Psychiatr Res; 2016 Jun; 77():27-34. PubMed ID: 26978182
[TBL] [Abstract][Full Text] [Related]
18. Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.
Kotterba S; Neusser T; Norenberg C; Bussfeld P; Glaser T; Dörner M; Schürks M
BMC Neurol; 2018 Aug; 18(1):123. PubMed ID: 30143019
[TBL] [Abstract][Full Text] [Related]
19. Discrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer disease.
Most EI; Aboudan S; Scheltens P; Van Someren EJ
Am J Geriatr Psychiatry; 2012 Jun; 20(6):460-7. PubMed ID: 22531105
[TBL] [Abstract][Full Text] [Related]
20. Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis.
Limmroth V; Malessa R; Zettl UK; Koehler J; Japp G; Haller P; Elias W; Obhof W; Viehöver A; Meier U; Brosig A; Hasford J; Putzki N; Kalski G; Wernsdörfer C;
J Neurol; 2007 Jan; 254(1):67-77. PubMed ID: 17273808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
